Cart
sales@molnova.com
DB07268
CAS No. 929007-72-7
DB07268( DB07268 | DB-07268 | DB 07268 )
Catalog No. M17669 CAS No. 929007-72-7
DB07268 is a potent and selective JNK1 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 113 | In Stock |
|
| 25MG | 224 | In Stock |
|
| 50MG | 405 | In Stock |
|
| 100MG | 597 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDB07268
-
NoteResearch use only, not for human use.
-
Brief DescriptionDB07268 is a potent and selective JNK1 inhibitor.
-
DescriptionDB07268 is is a potent and selective JNK1 inhibitor.
-
In VitroDB07268 (Compound 2b) also inhibits CHK1, PAK4, AKT1, and ERK2 with IC50s of 0.82 μM, 5.5 μM, 15 μM, and 25 μM, respectively.
-
In Vivo——
-
SynonymsDB07268 | DB-07268 | DB 07268
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorJNK1
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number929007-72-7
-
Formula Weight321.33
-
Molecular FormulaC17H15N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 32 mg/mL; 99.59 mM
-
SMILESc1cccc(c1Nc1ccnc(n1)Nc1cccc(c1)O)C(=O)N
-
Chemical Name2-((2-((3-hydroxyphenyl)amino)pyrimidin-4-yl)amino)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Liu M, et al. Bioorg Med Chem Lett. 2007 Feb 1;17(3):668-72.
molnova catalog
related products
-
BAY885
BAY885 is a new ERK5 inhibitor.
-
Patritumab
Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.
-
FR 180204
FR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively.
